Home
>
US Stocks
>
AnaptysBio Inc
AnaptysBio Inc
ANAB

AnaptysBio Inc

$27.9912.95%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
27.4
Today Low/High
27.4 / 27.99
52 Week Low/High
$13.92 / $35.85
P/E ratio
-79.3121
Market Cap
$691.05M

Company Details

Imsidolimab, previously known as ANB019, is an antibody that inhibits the function of the interleukin-36-receptor, or IL-36R, which AnaptysBio plans to initially develop as a potential first-in-class therapy for patients suffering from generalized pustular psoriasis, or GPP, EGFR-mediated skin toxicity, ichthyosis, hidradenitis suppurativa and acne.
Organisation
AnaptysBio Inc
Headquaters
San Diego, California, US
Employees
94
Industry
Health Technology
CEO
Hamza Suria

Discover more

Frequently Asked Questions

What is AnaptysBio Inc share price today

Can Indians buy AnaptysBio Inc shares?

How can I buy AnaptysBio Inc shares from India?

Can Fractional shares of AnaptysBio Inc be purchased?

What are the documents required to start investing in AnaptysBio Inc stocks?

We are a SEBI registered investement advisor